Results from the european survey on preoperative management and optimization protocols for PeriHilar cholangiocarcinoma.


Journal

HPB : the official journal of the International Hepato Pancreato Biliary Association
ISSN: 1477-2574
Titre abrégé: HPB (Oxford)
Pays: England
ID NLM: 100900921

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 30 12 2022
revised: 24 05 2023
accepted: 21 06 2023
pubmed: 6 8 2023
medline: 6 8 2023
entrez: 5 8 2023
Statut: ppublish

Résumé

Major surgery, along with preoperative cholestasis-related complications, are responsible for the increased risk of morbidity and mortality in perihilar cholangiocarcinoma (pCCA). The aim of the present survey is to provide a snapshot of current preoperative management and optimization strategies in Europe. 61 European centers, experienced in hepato-biliary surgery completed a 59-questions survey regarding pCCA preoperative management. Centers were stratified according to surgical caseload (<5 and ≥ 5 cases/year) and preoperative management protocols' application. The overall case volume consisted of 6333 patients. Multidisciplinary discussion was routinely performed in 91.8% of centers. Most respondents (96.7%) recognized the importance of a well-structured preoperative protocol. The preferred method for biliary drainage was percutaneous transhepatic biliary drainage (60.7%) while portal vein embolization was the preferred technique for liver hypertrophy (90.2%). Differences in preoperative pathologic confirmation of malignancy (35.8% vs 28.7%; p < 0.001), number of mismanaged referred patients (88.2% vs 50.8%; p < 0.001), biliary drainage (65.1% vs 55.6%; p = 0.015) and liver function evaluation (37.2% vs 5.6%; p = 0.001) were found between centers according to groups' stratification. The importance of a correct preoperative management is recognized. Nevertheless, the current lack of guidelines leads to wide heterogeneity of behaviors among centers. This survey can provide recommendations to improve pCCA perioperative outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Major surgery, along with preoperative cholestasis-related complications, are responsible for the increased risk of morbidity and mortality in perihilar cholangiocarcinoma (pCCA). The aim of the present survey is to provide a snapshot of current preoperative management and optimization strategies in Europe.
METHODS METHODS
61 European centers, experienced in hepato-biliary surgery completed a 59-questions survey regarding pCCA preoperative management. Centers were stratified according to surgical caseload (<5 and ≥ 5 cases/year) and preoperative management protocols' application.
RESULTS RESULTS
The overall case volume consisted of 6333 patients. Multidisciplinary discussion was routinely performed in 91.8% of centers. Most respondents (96.7%) recognized the importance of a well-structured preoperative protocol. The preferred method for biliary drainage was percutaneous transhepatic biliary drainage (60.7%) while portal vein embolization was the preferred technique for liver hypertrophy (90.2%). Differences in preoperative pathologic confirmation of malignancy (35.8% vs 28.7%; p < 0.001), number of mismanaged referred patients (88.2% vs 50.8%; p < 0.001), biliary drainage (65.1% vs 55.6%; p = 0.015) and liver function evaluation (37.2% vs 5.6%; p = 0.001) were found between centers according to groups' stratification.
CONCLUSION CONCLUSIONS
The importance of a correct preoperative management is recognized. Nevertheless, the current lack of guidelines leads to wide heterogeneity of behaviors among centers. This survey can provide recommendations to improve pCCA perioperative outcomes.

Identifiants

pubmed: 37543473
pii: S1365-182X(23)00568-3
doi: 10.1016/j.hpb.2023.06.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1302-1322

Investigateurs

Robert Sutcliffe (R)
Pim Olthof (P)
Andrea Ruzzenente (A)
Florin Botea (F)
Enrico Gringeri (E)
Fabian Bartsch (F)
Nadia Russolillo (N)
Carlo Sposito (C)
Matteo Serenari (M)
Francesco Ardito (F)
Jonathan Garnier (J)
Asmund Fretland (A)
Arpad Ivanecz (A)
Olivier Scatton (O)
Andrii Lukashenko (A)
Santi L Ben (SL)
Miguel A Lopez Bravo (MA)
Ajith Siriwardena (A)
Marc Schiesser (M)
Elio Jovine (E)
Bas G Koerkamp (BG)
Olivier Soubrane (O)
Cornelis H Dejong (CH)
Fabrice Muscari (F)
Andre Trudnikov (A)
Ville Sallinen (V)
Par Sandstrom (P)
Giedrius Barauskas (G)
Jiri Pudil (J)
Bergthor Bjornsson (B)
Lilian Schwarz (L)
Erik Schadde (E)
Thomas Gruenberger (T)
Fernando Rotellar (F)
Dervenis Christos (D)
Vladislav Treska (V)
David Fuks (D)
Jan Schmidt (J)
Fatih M Can (FM)
Fernando P Aranda (FP)
Michal Solecki (M)

Informations de copyright

Copyright © 2023 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest None to declare.

Auteurs

Francesca Ratti (F)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milano, Italy. Electronic address: ratti.francesca@hsr.it.

Rebecca Marino (R)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milano, Italy.

Paolo Muiesan (P)

Queen Elizabeth Hospital Birmingham, Birmingham, UK.

Krzysztof Zieniewicz (K)

Dept of General, Transplant and Liver Surgery, Medical University, Warsaw, Poland.

Tomas Van Gulik (T)

Academic Medical Center, Erasmus Medica Center, Amsterdam, the Netherlands.

Alfredo Guglielmi (A)

General and Hepatobiliary Surgery, University of Verona, Verona, Italy.

Hugo P Marques (HP)

Curry Cabral Hospital, Lisboa, Portugal.

Valdivieso Andres (V)

Cruces University Hospital, Bilbao, Spain.

Andreas Schnitzbauer (A)

Frankfurt University Hospital, Frankfurt, Germany.

Popescu Irinel (P)

Center of General Surgery and Liver Transplant, Fundeni Clinical Institut, Bucharest, Romania.

Moritz Schmelzle (M)

Charite-Universitatsmedizin Berlin, Berlin, Germany.

Ernesto Sparrelid (E)

Karolinska University Hospital, Stockholm, Sweden.

Giuseppe K Fusai (GK)

Royal Free Hospital, London, UK.

Renè Adam (R)

Paul Brousse University Hospital, Paris, France; Assistance Publique - Hôpitaux de Paris, Paris, France.

Umberto Cillo (U)

Hepatobiliary Surgery and Liver Transplantation Unit, Padova, Italy.

Hauke Lang (H)

University Medical Center Mainz, Mainz, Germany.

Karl Oldhafer (K)

Asklepios Hospital Barmbek, Hamburg, Germany.

Alikhanov Ruslan (A)

Moscow Clinical Scientific Center, Moscow, Russia.

Ruben Ciria (R)

University Hospital Reina Sofia, Cordoba, Spain.

Alessandro Ferrero (A)

Ospedale Mauriziano Umberto I, Torino, Italy.

Vincenzo Mazzaferro (V)

University of Milan, Department of Oncology and Hemato-Oncology, Istituto Nazionale Tumori, Milan, Italy.

Matteo Cescon (M)

Ospedale Sant'Orsola Malpighi, Bologna, Italy.

Felice Giuliante (F)

Foundation Policlinico Universitario Gemelli, Roma, Italy.

Silvio Nadalin (S)

University Hospital Tubingen, Tubingen, Germany.

Nicolas Golse (N)

Paul Brousse University Hospital, Paris, France.

Laurent Sulpice (L)

University Hospital of Rennes, Renne, France.

Alejandro Serrablo (A)

Miguel Servet University Hospital, Zaragoza, Spain.

Emilio Ramos (E)

Hospital Universitario de Bellvitge, Barcelona, Spain.

Ugo Marchese (U)

Institute Paoli Calmettes, Marseille, France.

Bard Rosok (B)

Oslo University Hospital, Oslo, Norway.

Victor Lopez-Lopez (V)

Clinic and University Virgen de La Arrixaca Hospital, Murcia, Spain.

Pierre Clavien (P)

University Hospital Zurich, Zurich, Switzerland.

Luca Aldrighetti (L)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milano, Italy.

Classifications MeSH